| 0.45 Data as of May 24 |  -0.02 / -4.26%Today’s Change | 0.22 Today|||52-Week Range 3.99 | -26.84% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP -- |
PURE Bioscience, Inc. 1725 Gillespie Way El Cajon California 92020-1098 |
| Individual stakeholders | 1.88% |
| Mutual fund holders | 1.53% |
| Other institutional | 1.04% |
| Michael L. Krall | Chairman, President & Chief Executive Officer |
| Peter C. Wulff, MBA | Chief Financial & Accounting Officer |
| Donna M. Singer | Director, Executive VP & Head-Investor Relations |
| Tom Myers | Executive Vice President-Sales & Marketing |
| Dennis B. Atchley | Secretary |
.
